Skip to main content
SpringerLink
Log in

In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the levels of anti-inflammatory interleukin-10 and pro-inflammatory cytokines and their relationship to endothelial function in patients with idiopathic venous thrombosis. Forty-nine eligible patients of both sexes with idiopathic venous thrombosis and 48 matched control subjects were studied. Levels of inflammatory markers were determined. Endothelial function was evaluated by ultrasound measurement of the flow mediated dilatation (FMD) of the brachial artery. Compared to the control group, patients with idiopathic venous thrombosis had significantly lower levels of interleukin-10 1.81 pg/ml (1.53–2.21) versus 2.71 pg/ml (1.84–3.65), p < 0.001. Patients also had increased levels of pro-inflammatory cytokines: interleukin-6 2.37 pg/ml (1.59–4.09) versus 2.03 pg/ml (1.49–2.59), p = 0.025, interleukin-8 3.53 pg/ml (2.94–5.30) versus 2.25 pg/ml (1.77–2.90), p < 0.001. Furthermore, decreased FMD was observed in patients: 5.0% (3.9–6.9) versus 12.7% (10.8–15.6), p < 0.001. FMD was related to levels of interleukin-10 (r = 0.33, p = 0.001) and was inversely related to pro-inflammatory cytokines interleukin-6 (r = −0.34, p = 0.001) and interleukin-8 (r = −0.43, p < 0.001). Patients with idiopathic venous thrombosis have decreased levels of IL-10 and increased levels of pro-inflammatory cytokines. This imbalance indicates that in the stable phase of the disease, patients have an increased systemic inflammatory response. This inflammatory response could be the consequence of the disease, but most probably is involved in the pathogenesis of venous thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979

    Article  PubMed  CAS  Google Scholar 

  2. Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9–I16

    Article  PubMed  Google Scholar 

  3. Conde I, Lopez JA (2005) Classification of venous thromboembolism (VTE). Role of acute inflammatory stress in venous thromboembolism. J Thromb Haemost 3:2573–2575

    Article  PubMed  CAS  Google Scholar 

  4. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ (1997) Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 5:6–15

    Article  PubMed  CAS  Google Scholar 

  5. Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539–552

    Article  PubMed  CAS  Google Scholar 

  6. Reitsma PH, Rosendaal FR (2004) Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2:619–622

    Article  PubMed  CAS  Google Scholar 

  7. Downing LJ, Strieter RM, Kadell AM, Wilke CA, Austin JC, Hare BD, Burdick MD, Greenfield LJ, Wakefield TW (1998) IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 161:1471–1476

    PubMed  CAS  Google Scholar 

  8. Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman M (1993) Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700–2703

    Article  PubMed  CAS  Google Scholar 

  9. Del Prete G, De Carli M, Lammel RM, D’Elios MM, Daniel KC, Giusti B, Abbate R, Romagnani S (1995) Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86:250–257

    PubMed  CAS  Google Scholar 

  10. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102:1000–1006

    PubMed  CAS  Google Scholar 

  11. Bhagat K, Vallance P (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96:3042–3047

    PubMed  CAS  Google Scholar 

  12. Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, Falcinelli E, Ciabattoni G, Dalla Valle F, Prandoni P, Agnelli G, Gresele P (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92:812–818

    Article  PubMed  CAS  Google Scholar 

  13. Jezovnik MK, Poredos P, Stalc M (2010) Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis. J Atheroscler Thromb 17:1190–1198

    Article  PubMed  Google Scholar 

  14. Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher AM (2004) Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 44:44–49

    Article  PubMed  CAS  Google Scholar 

  15. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265

    Article  PubMed  Google Scholar 

  16. Celermajer DS (1998) Noninvasive detection of atherosclerosis. N Engl J Med 339:2014–2015

    Article  PubMed  CAS  Google Scholar 

  17. Christiansen SC, Naess IA, Cannegieter SC, Hammerstrom J, Rosendaal FR, Reitsma PH (2006) Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med 3:e334

    Article  PubMed  Google Scholar 

  18. Dosquet C, Weill D, Wautier JL (1995) Cytokines and thrombosis. J Cardiovasc Pharmacol 25(Suppl 2):S13–S19

    Article  PubMed  CAS  Google Scholar 

  19. Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C (2009) Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 24:22–26

    Article  PubMed  Google Scholar 

  20. Derosa G, Ferrari I, D’Angelo A, Salvadeo SA, Fogari E, Gravina A, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AF (2009) Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels 24:204–210

    Article  PubMed  Google Scholar 

  21. Bergman M, Djaldetti M, Salman H, Bessler H (2010) On the combined effect of statins and lycopene on cytokine production by human peripheral blood cells. Heart Vessels 25:426–431

    Article  PubMed  Google Scholar 

  22. Roumen-Klappe EM, den Heijer M, van Uum SH, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H (2002) Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 35:701–706

    Article  PubMed  Google Scholar 

  23. Proctor MC, Sullivan V, Zajkowski P, Wolk SW, Pomerantz RA, Wakefield TW, Greenfield LJ (2006) A role for interleukin-10 in the assessment of venous thromboembolism risk in injured patients. J Trauma 60:147–151

    Article  PubMed  CAS  Google Scholar 

  24. Poredos P (2004) Involvement of endothelial dysfunction in atherogenesis. In: Clark JV (ed) Focus on atherosclerosis research. Nova Science Publishers, Inc, Hauppauge, NY, USA, pp 165–183

    Google Scholar 

  25. Taddei S, Salvetti A (2002) Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 20:1671–1674

    Article  PubMed  CAS  Google Scholar 

  26. Poredos P, Kek A (2000) Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria. Am J Cardiol 86:364–367

    Article  PubMed  CAS  Google Scholar 

  27. Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108–1111

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Vascular Disease, University Medical Centre Ljubljana, Zaloska 7, 1000, Ljubljana, Slovenia

    Pavel Poredos & Mateja Kaja Jezovnik

Authors
  1. Pavel Poredos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mateja Kaja Jezovnik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pavel Poredos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poredos, P., Jezovnik, M.K. In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction. Heart Vessels 26, 596–602 (2011). https://doi.org/10.1007/s00380-010-0111-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-010-0111-3

Keywords

Search

Navigation